<DOC>
	<DOCNO>NCT00211744</DOCNO>
	<brief_summary>A 12-week program examine effectiveness topiramate adjunctive treatment adult obsessive-compulsive disorder currently serotonin reuptake inhibitor medication ( age 18-65 ) .</brief_summary>
	<brief_title>Topiramate Augmentation Treatment Obsessive-Compulsive Disorder</brief_title>
	<detailed_description>The Compulsive , Impulsive Anxiety Disorders Program Mount Sinai School Medicine conduct study Topiramate ( Topamax ) add SSRI management treatment-resistant Obsessive-Compulsive Disorder . The purpose study evaluate safety efficacy Topiramate versus placebo add selective serotonin reuptake inhibitor ( SRI ) patient treatment resistant OCD . The program 12 week duration involve regular visit psychiatrist well complete psychiatric medical evaluation . Treatment medication study provide free charge.Participants must age 18 65 onset OCD least 1 year prior screen . In addition , participant must take clinically effective dose SSRI least 3 month must maintain current dose throughout study . Participants must primary OCD symptom hoarding .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Males Females 1865 year age diagnose OCD currently take SSRI medication ( ) major medical disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>OCD</keyword>
	<keyword>Obsessive-Compulsive Disorder</keyword>
	<keyword>OCD treatment</keyword>
</DOC>